Affinity Asset Advisors »

Verona Pharma Plc ads shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Verona Pharma Plc ads (VRNA) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Verona Pharma Plc ads

Tip: Access up to 7 years of quarterly data

All positions including Verona Pharma Plc ads held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verona Pharma Plc ads by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.0M 368k 16.30
2023-06-30 $9.5M 448k 21.14
2023-03-31 $9.1M 453k 20.08
2022-12-31 $11M 418k 26.13
2022-09-30 $5.3M 515k 10.22

More positions owned by Affinity Asset Advisors

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Apogee Therapeutics (APGE)
Establishment Labs Holdings Ord (ESTA)
Cymabay Therapeutics
Immunovant (IMVT)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Madrigal Pharmaceuticals (MDGL)
Xenon Pharmaceuticals (XENE)
Alkermes SHS Call Option (ALKS)
Kura Oncology (KURA)
Astria Therapeutics (ATXS)
Morphic Hldg (MORF)

View all positions for Affinity Asset Advisors

Top funds holding Verona Pharma Plc ads

RA Capital Management
NEA Management Company
Perceptive Advisors
Wellington Management Company
OrbiMed Advisors
Vivo Capital
Frazier Life Sciences Management
Federated Investors
Carlyle
Octagon Capital Advisors
Henderson Group
Maverick Capital
Jennison Associates
Eventide Asset Management
Aisling Capital Management

View all funds holding Verona Pharma Plc ads